Covid Omicron Travel Routes / Infections When the United States makes the above list...lets see what our count is going to be. wrbtrader
You should note that within days of Austria locking down the unvaccinated — Covid cases started to fall rapidly with a steep slope of decline.
Yes but how does Austria have an omicron outbreak when all their un-vaxxed citizens are under house arrest.
Do you think "all of them" are staying home under house arrest or out protesting ??? Also, I think they're allowed to go to work and shopping but its obvious they've added "protesting" to their "things to do" list. Maybe one day soon, I will look at their Covid hospitalization, ICU admission, and hospital capacity numbers to see what's really going on to prompt a 10-day lockdown. wrbtrader
First - let's walk through the time table and steps for a vaccine-focused peer-reviewed main-stream medical paper: First - data must be gathered over a time period where it would be considered to be statistically significant sample - typically this would be two or three months minimum. Keep in mind that Delta only appeared significantly in the western world (outside of India) in June of 2021 Second - the researcher and co-authors must write the paper based on the data. This typically will take three months. Third - the paper must go peer review which typically takes at least three months even when it is expedited. The latest nonsense being pushed broadly across social media and blogs by anti-vaxxers are demands for "peer-reviewed papers showing vaccines are safe and effective against Delta" - This is the latest bullshiat rallying cry of anti-vax nutcases. Obviously seeing that we are only 5 or 6 months into the Delta wave in the western world -- there has not been sufficient time yet to complete the review cycles to create peer-reviewed paper. At this point there are numerous pre-print studies on the effectiveness of vaccines against Delta by respected scientific authors but they are not peer-reviewed yet. Some of these should complete peer review near the end of Q! of 2022. Second - let's walk through the anti-vax screed demanding papers showing vaccines are "safe and effective" against Delta. Papers will either focus on if a vaccine is "effective" or it will focus on if a vaccine is "safe". Studies are narrow by definition -- there will likely never be a primary peer-reviewed study showing a vaccine is both "safe" and "effective" against Delta; these are two totally different areas of research focus for a study. So demanding a peer-reviewed study showing vaccines are "safe and effective" against Delta -- is just another pile of bullshiat being knowingly shoveled by anti-vaxxers. Bottom line: We are not going to play this game with anti-vaxxers who continue to issue demands as part of their methods to shovel nonsensical turds -- misinformation which is killing tens of thousands people around the globe. Of course when you actually produce a peer-reviewed study showing Covid vaccines are safe they immediately revert to pushing fabricated nonsense about VAERS to claim the vaccines are not safe -- so even when you produce the proof, the anti-vaxxers just move on to other bullshiat. These anti-vaxxers are irredeemable.
At some point in time...you'll just not take any statements from obvious Covidiots as something to respond to because they're baiting for a debate just to be an idiot. Yet, the Covidiot parrots requesting data not YET released need to either directly contact a well-known laboratory doing Covid research, subscribe to premium Covid data that Hospitals subscribe too, worked in the field of Immunology / Genetics / Virology in the past but still have close friends in the field that are happy to send data to you as part of a private conversation or learn better research skills. If the above is not suitable for the Covidiot...just tell them to Shut The Fuck Up...enough with the parrot-like bullshit requests...info they will ignore anyway after you send it to them. I already see the same asswipes requesting data about Omicron when research labs are clearly stating we don't know enough about it and we'll have our first set of data about Omicron and Vaccines efficacy/effectiveness against Omicron in a few weeks...I'm assuming that's before Christmas. Until then, we do have real-life data about Delta Variant impact on North America. I've posted countless statistics, graphs about Canada and the United States... Being vaccinated works very well here in North America in preventing Covid hospitalization, ICU admission, and Deaths. Yet, more than 90% that are Covid hospital admission, ICU admission, or Death here in North America...were not vaccinated. This is data easily available from any state or province in North America. All of this data request bullshit, peer-review request bullshit reminds me of the Covidiot playbook by jem. The best counter was to post Covid data from the Public Health Agency of his city he lived in and the state he lived in with contact info if he disliked the data of...San Diego, California. He stopped quickly with that bullshit and soon disappeared from the forum. wrbtrader
I have found a study comparing Covid breakthrough cases in the immunocompromised compared to non-compromised individuals. Nothing on the average length of infection however. Study shows breakthrough COVID-19 infections occur more often and are more severe in immunocompromised https://medicalxpress.com/news/2021-11-breakthrough-covid-infections-severe-immunocompromised.html A real-world retrospective cohort study involving nearly 1.2 million people shows COVID-19 infections in the 'fully' vaccinated are rare but are more common and severe in people with weaker immune systems. The findings, published today in the Journal of Medical Economics, are led by researchers from Pfizer, which has co-developed [with BioNTech] one of three currently available COVID-19 vaccines in the United States. Analyzing healthcare records, the study team found within their pool of fully vaccinated people only 0.08% experienced a breakthrough infection between December 10, 2020 and July 8, 2021. However, although immunocompromised individuals represented just 18% of those studied, they accounted for over 38% of infections; nearly 60% of all hospitalizations; and 100% of deaths. The proportion of people with breakthrough infections was three times higher among immunocompromised individuals (0.18%) than among the reference group of non-immunocompromised individuals (0.06%). "The results supplement other real-world studies, and support the introduction of a third dose of a COVID-19 vaccine to increase protection among the immunocompromised individuals"—states Manuela Di Fusco, lead author from the Pfizer Health Economics and Outcomes Research team. "Several countries are currently experiencing a resurgence of SARS-CoV-2 infections despite the rollout of mass vaccination programmes. While COVID-19 mRNA vaccines help protect people from getting infected and severely ill, the risk of breakthrough infections in fully vaccinated people is not completely eliminated." Identifying individuals in the US population who had received two doses of the Pfizer/BioNTech (BNT162b2) COVID-19 mRNA vaccine, the Pfizer study looked to examine breakthrough infections among those with and without a weakened immune system. From a large collection of US healthcare administrative data, the team analysed healthcare records of 1,277,747 people aged 16 or over who had received two doses of the BNT162b2 COVID-19 mRNA vaccine between December 10, 2020 and July 8, 2021. Of this group, 225,796 (17.7%) were identified as immunocompromised—including people with advanced HIV/AIDS, cancer, kidney disease, rheumatologic or other inflammatory conditions, other immune conditions, and bone marrow or organ transplant recipients. The study results showed: A total of 978 (0.08%) breakthrough infections occurred among 1,176,907 fully vaccinated individuals who had at least two weeks of follow-up after the second dose. 124 (12.7%) of these breakthrough infections required hospital treatment. Of them, 74 (59.7%) were immunocompromised, and two people died (both immunocompromised). 2% of all breakthrough infections (374 out of 978) occurred in those who were immunocompromised "While the study leveraged a large dataset that has been previously used for healthcare research in the US, the findings should be interpreted in the context of multiple limitations, including coding accuracy and data representativeness beyond the study period" says Di Fusco. On 12 August 2021, the US FDA authorized an additional dose of an approved COVID-19 mRNA vaccine in certain immunocompromised individuals and the Centers for Disease Control and Prevention (CDC) recommended that moderately to severely immunocompromised people should receive an additional dose of the COVID-19 vaccine. On 1 September 2021, the UK's Joint Committee on Vaccination and Immunization (JCVI) advised that people over 12 with severely weakened immune systems should have a third dose of mRNA vaccine as part of their primary vaccination schedule. On 11 October 2021, the World Health Organization (WHO) recommended that people with weakened immune systems should receive an additional dose of a COVID-19 vaccine, due to their higher risk of breakthrough infections after standard vaccination. "Our study results advance the understanding of post-vaccination outcomes and support recent recommendations to provide a third primary series dose of an mRNA COVID-19 vaccine to patients with weaker immune systems after the initial two doses", adds Di Fusco.